Skip to main content
. 2017 Feb 14;8(3):299–303. doi: 10.1021/acsmedchemlett.6b00465

Table 4. Monkey PKa Profile of (+)/(−)-Lesinurad after a Single Dosing of (±)-Lesinurad.

parameters (−)-lesinurad (+)-lesinurad (−)/(+)-index
IV doseb 2 mg/kg of (±)-lesinurad
AUC0-inf (μM·h) 14.5 ± 3.3 10.0 ± 2.8 1.4
CLp (mL/min/kg) 5.9 ± 1.5 8.8 ± 2.7 0.7
C0–24h,urine (μM) 5.4 ± 0.9 2.8 ± 1.4 1.9
PO dosec 10 mg/kg of (±)-lesinurad
AUC0-inf (μM·h) 99.4 ± 29.7 28.2 ± 19.2 3.5
C0–24h,urine (μM) 153.3 ± 93.5 38.0 ± 20.7 4.0
a

Monkey PK data is mean ± SD, n = 3.

b

IV formulation: 2.00 mg/mL in DMSO/PEG400/H2O(5/40/55), clear solution.

c

PO formulation: 2 mg/mL in DMSO/0.5%MC(5/95), suspension.